Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Some sterile use packages of graft carrier devices were not sealed prior to sterilization. the seal end of the package (flat pouch) for the individual unit may not have been applied.
Model Catalog: 00-7716-000-10 (Lot serial: GREATER THAN 100); Model Catalog: 00-7708-000-10 (Lot serial: GREATER THAN 100); Model Catalog: 00-2195-012-00 (Lot serial: GREATER THAN 100); Model Catalog: 00-2195-013-00 (Lot serial: GREATER THAN 100); Model Catalog: 00-2195-014-00 (Lot serial: GREATER THAN 100)
“The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.